stockrowAmgen Inc. (AMGN) vs Gilead Sciences, Inc. (GILD)
- Amgen Inc. AMGN 460.42 +0.03%
- Gilead Sciences, Inc. GILD 166.89 −0.41%
Amgen Inc. and Gilead Sciences, Inc. are both Drug Manufacturers General companies. Amgen Inc. is the larger, with a market value of $248.8B against $207.8B — 1.2× the size. Gilead Sciences, Inc. has negative trailing earnings, so its P/E is not meaningful; Amgen Inc. trades at 26.5×. Amgen Inc. grew revenue faster over the last twelve months: 8.15% against 6.54%. Amgen Inc. has the higher net margin (24.1% vs −12.5%) and the higher return on invested capital (14.3% vs −4.51%). Both pay a dividend; Amgen Inc. yields more (2.16% vs 1.95%). Across the 22 metrics below, Amgen Inc. leads on 12 and Gilead Sciences, Inc. on 10.
Valuation
Profitability
| Metric | AMGN | GILD | Drug Manufacturers General median |
|---|---|---|---|
| Gross margin | 70.90% | 79.93% | 73.01% |
| Operating margin | 32.41% | (7.63%) | 18.34% |
| Net margin | 24.14% | (12.47%) | 7.31% |
| Free cash flow margin | 24.63% | 44.47% | 18.56% |
| Return on equity | 78.35% | (22.45%) | 5.80% |
| Return on assets | 10.09% | (7.03%) | 2.28% |
| Return on invested capital | 14.29% | (4.51%) | 6.26% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack